Katie Ellias

Verified profile

Venture Capital, Investor · United States

Katie Ellias is a venture capital investor and investor based in the United States. They invest in AngularJS, Education, Biotechnology and Electronic Health Records (EHR), typically at the Seed stage. Their portfolio includes Tetragenetics, Biolinq, Enthera and Provention Bio and 19 other companies.

Investment stages

Industries

Portfolio companies (23)

Similar investors in AngularJS

  • Rafael RomeroVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsE-commerceWomen Founded

    Portfolio: Frequency Therapeutics, Lev Pharmaceuticals

    Contact details available

  • Andrew LeVerified

    Angel/Individual, Investment Partner · United States

    SeedHealth CareEvents ServicesWellnessWomen Founded

    Portfolio: TAMP

    Contact details available

  • Vikas BatraVerified

    Angel/Individual · United States

    Health CareTelecommunicationsE-commerceEnterprise Software

    Contact details available

  • Srinivas Mandyam

    Angel/Individual · United States

    SeedDigital MediaAngularJSEducationK-12 Education

    Portfolio: PipelineDB

    Contact details available

  • Lindsey N.

    Angel/Individual · United States

    CryptocurrencyMusicAngularJSRetail

    Portfolio: Audius

    Contact details available

  • David HammerVerified

    Angel/Individual · United States

    AdvertisingHealth CareE-commerceEnterprise Software

    Portfolio: Bread, Albert

    Contact details available

  • Peter LeonardVerified

    Angel/Individual · United States

    AdvertisingE-commerceAndroidApps

    Contact details available

  • James RozziVerified

    Angel/Individual · United States

    Health CareCybersecurityEnterprise SoftwareTransportation

    Portfolio: Aceable, sxtyscnds

    Contact details available